Download information about Clinipace Worldwide and our CRO services.
This infographic (based on information from the April 11 live webcast) provides an overview of oncology clinical trials.
This infographic (based on information from the February 11, 2014 live webcast) provides an overview of the underrepresented in oncology trials and the accrural process.
This infographic (based on information from the April 30 live webcast) provides a global view of infectious disease.
Supplemental information from the February 28th webcast including Regulatory Guidance 2011 (Key Messages) and Cost Trajectory in Clinical Trials.
This supplemental information from the February 14 live webcast provides a deep dive into key presentation topics.
Learn how Clinipace's digital CRO service delivery model reduces phase 2 trial costs, provides greater transparency, and better quality control.
In a recent cardiovascular medical device study, the sponsor estimates a total cost savings of 50 to 60% - over $2M – in project management savings by deploying Clinipace’s digital CRO model.
Results Driven by our Experts, Advanced by our Technology
As a digital contract research organization (dCRO), Clinipace Worldwide pioneered an innovative service model to transform drug and medical device development by delivering technology-amplified services to improve performance, collaboration, and visibility across all stakeholders.
The Power of the Digital CRO
Operationalize Your Clinical Trial Protocol
Whether you’re engaged in a single site, 25 patient phase I study, a phase II trial, large global phase III trial with dozens of sites and thousands of patients or a phase IV safety study, we can help you affordably operationalize your clinical trial protocol and gain visibility into your clinical development program or individual project.
Enhance the Strategic Development of your Product with Specialized Expertise
We develop high-level regulatory strategies to expedite products through clinical development and into the market. As a global digital contract research organization (dCRO), we specialize in providing a full complement of strategic drug development services for emerging to large multinational life science firms.